ESR1 and breast carcinoma: For younger age group of breast cancer patients, there is a higher frequency of grade 3 tumors, higher lymphatic invasion, lower estrogen receptor (ER) and progesterone receptor (PR) positivity, higher human epidermal growth factor receptor 2 (HER-2) expression, and larger tumors [1, 26, 27].